Innovus Pharmaceuticals, Inc.

CIK 1411879 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Innovus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 26, 202015-12G0001437749-20-003529
Feb 25, 2020S-8 POS0001437749-20-003479
Feb 25, 2020S-8 POS0001437749-20-003478
Feb 25, 2020S-8 POS0001437749-20-003476
Feb 25, 2020S-8 POS0001437749-20-003474
Feb 25, 2020S-8 POS0001437749-20-003473
Feb 25, 2020S-8 POS0001437749-20-003480
Feb 25, 2020S-8 POS0001437749-20-003475
Feb 20, 2020SC 13D/A0000919574-20-001775
Feb 19, 202040000919574-20-001732
Feb 19, 202040000919574-20-001731
Feb 14, 20208-K0001437749-20-002798
Feb 14, 20208-K0001437749-20-002658
Jan 15, 2020SC 13G0001798208-20-000002
Jan 7, 202040001437749-20-000321
Jan 7, 202040001437749-20-000322
Jan 7, 202040001437749-20-000323
Nov 14, 201910-Q0001437749-19-022728
Oct 3, 20194250001654954-19-011428
Oct 2, 201940001437749-19-019541
Oct 2, 201940001437749-19-019543
Oct 2, 201940001437749-19-019542
Sep 23, 20194250001654954-19-010996
Sep 19, 2019SC 13D/A0000919574-19-005934
Sep 18, 20194250001437749-19-018642